Cena akcií Ocuphire Pharma Inc ($OCUP), kotace a zprávy

Obchodujte

Cena

4.10% Minulý týden

Tržní kapitalizace

34.06M

Denní rozsah

1.22

-

1.28

Rozsah za 52 týdnů

1.12

-

4.50

Objem (3 měsíce)

152.96K

Poměr ceny a zisku

-2.36

Příjmy

16.45M

Připnutá zpráva

eToro

před 5 měsíci

🚚 Happy Thursday! We have a BIG surprise for you 😍 🔊 We're happy to announce the addition of 𝟓𝟎𝟗 new stocks and ETFs to our already extensive lineup of investment options. 🎊 With these additions, we reach a spectacular number of almost 6000 assets on the platform! $LLFLQAP $RGTI (Rigetti... Zobrazit více Přeložit

Diskuze o Top

Austrálie

před 2 měsíci

$OCUP (Ocuphire Pharma Inc) @_etoro why the price is different from your app and trade view? Currently in trade view it is 1.59 and in you app, it is 1.50. Why there is a huge difference? Přeložit

Ocuphire Pharma Inc

1.27

0.05 (4.10%)

Obchodovat

@PrivateAnastasia

Itálie

před 4 měsíci

$SCYX (Scynexis Inc) finance.yahoo.com/news/scynexis-q1-earnings-snapshot-205135866.html $VHT $OCUP (Ocuphire Pharma Inc) $VRTX (Vertex Pharmaceuticals Incorporated) $02269.HK (Wuxi Biologics Cayman Inc) $1530.HK (3SBio Inc)

Scynexis: Q1 Earnings Snapshot

finance.yahoo.com

JERSEY CITY, N.J. (AP) — Scynexis Inc. SCYX) on Wednesday reported earnings of $411,000 in its first quarter. On a per-share basis, the Jersey City, New Jersey-based company said it had net income of 1 cent.

Itálie

před 4 měsíci

Il mio portafoglio è aumentato di 2.10% nell'ultima settimana! controlla www.etoro.com/it/people/patoverg/portfolio $OCUP (Ocuphire Pharma Inc) $FNGU $META (Meta Platforms Inc) $UIS (Unisys Corp) Přeložit

Itálie

před 4 měsíci

Il mio portafoglio è aumentato di 1.60% nell'ultima settimana! controlla www.etoro.com/it/people/patoverg/portfolio $OCUP (Ocuphire Pharma Inc) $NVDA (NVIDIA Corporation) $CELH (Celsius Holdings Inc.) $FICO (Fair Isaac Corporation) $FNGU Přeložit

Patoverg's trading portfolio on eToro.com

Marketing management passione per il trading a lungo termine e intraday trading livello di rischio 4/5

Itálie

před 4 měsíci

Il mio portafoglio è aumentato di 1.41% nell'ultima giornata! controlla www.etoro.com/it/people/patoverg/portfolio $OCUP (Ocuphire Pharma Inc) $NVDA (NVIDIA Corporation) $FNGU Přeložit

Itálie

před 4 měsíci

Esamina la pagina di $OCUP (Ocuphire Pharma Inc) www.etoro.com/it/markets/ocup 🚀🚀 Přeložit

Ocuphire Pharma Inc

1.27

0.05 (4.10%)

Obchodovat

Itálie

před 4 měsíci

Il mio portafoglio è aumentato di 1.65% nell'ultima giornata! controlla www.etoro.com/it/people/patoverg/portfolio $OCUP (Ocuphire Pharma Inc) Přeložit

Ocuphire Pharma Inc

1.27

0.05 (4.10%)

Obchodovat

@PrivateAnastasia

Itálie

před 4 měsíci

$OCUP (Ocuphire Pharma Inc) www.openpr.com/news/3482857/myopia-and-presbyopia-eye-drops-market-expected-to-expand-at $XLV $VHT

Myopia And Presbyopia Eye Drops Market Expected to Expand at a Steady 2024-2031 | Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals

Myopia And Presbyopia Eye Drops Market report published by Coherent Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions The research scope provides comprehensive market size and other in depth ...

@PrivateAnastasia

Itálie

před 5 měsíci

Opraveno

$OCUP (Ocuphire Pharma Inc) finance.yahoo.com/news/ocuphire-pharma-announces-apx3330-presentation-120000015.html $XLV $VHT

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting

finance.yahoo.com

FARMINGTON HILLS, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that Daniel Su, M.D. will deliver a paper presentation on oral APX3330 at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held May 5-9, 2024 in Seattle, Washington. Key details about Dr. Su’s pres

Lidé také koupili

Sat Sep 14 2024 12:07:18 GMT+0000 (Coordinated Universal Time)